Ben Zhong Tang shares the story behind aggregation-induced emission and reflects on its impact across chemistry and materials science.
Jenna Flogeras
Jenna Flogeras is a science writer and editor with an M.Sc. in inorganic chemistry from the University of New Brunswick, Canada. She covers research across the physical and life sciences, including chemistry, AI, materials science, health, and sustainability. A longtime traveler, she works remotely while reporting from around the world.
Nature-inspired materials that move and change color on demand
A photonic actuator with separate mechanisms for color change and motion could enable smarter soft robots and sensors.
Beyond net zero: converting carbon dioxide into solid carbon for long-term storage
Researchers have developed a tandem process that converts carbon dioxide into carbon nanofibers, offering a route to net-negative emissions.
Beyond textiles: polyamides reimagined as light-emitting materials
Researchers have designed a heat-resistant polyamide that generates white light without added dyes or dopants.
Hybrid electrolysis replaces waste oxygen with valuable chemicals
A hybrid electrolysis system produces hydrogen while upgrading glycerol into valuable chemicals.
Transforming agricultural waste into water and energy solutions in Mozambique
Combining spatial analysis with community engagement, researchers are identifying where agricultural waste can help solve water and energy challenges in rural areas.
Drug-free hair regrowth via cold plasma treatments
Using cold plasma, researchers are targeting the hair follicle microenvironment to encourage hair regrowth.
Alexis Komor, Expanding the Gene Editing Toolbox
Young Innovator Awardee for 2025, Komor leads a group at UCSD developing precision genome editing methods using chemical biology.
Haitham Amal: targeting autism spectrum disorder, Alzheimer’s disease, and glioblastoma with small-molecule drugs
With FDA orphan drug approval secured, Amal and his team are preparing for phase 1 clinical trials of their small-molecule drugs in 2026.
Immune resilience gene signature could hold the key to healthy aging
High levels of a certain biomarker gives people a survival advantage, study finds.